-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HyW33dHY8gIFzkGPs5/ecjFlceuV0TR+rLlHMmVto5nafiycWFiG2y1cFbH4jI2f ZJYKrtV0y/b9LtdMrDgPsw== 0001412292-10-000003.txt : 20100301 0001412292-10-000003.hdr.sgml : 20100301 20100301160021 ACCESSION NUMBER: 0001412292-10-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100225 FILED AS OF DATE: 20100301 DATE AS OF CHANGE: 20100301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Darazsdi Daniel G CENTRAL INDEX KEY: 0001412292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10644467 MAIL ADDRESS: STREET 1: C/O PHARMACEUTICAL PRODUCT DEVELOPMENT STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-02-25 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001412292 Darazsdi Daniel G 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 Chief Financial Officer Common Stock 11482 D Stock Options (to buy) 21.17 2010-02-25 4 A 0 60000 0 A 2011-02-25 2020-02-25 Common Stock 60000 60000 D Stock Options (to buy) 26.64 2010-02-18 2019-02-18 Common Stock 60000 60000 D Stock Options (to buy) 20.64 2009-11-20 2018-11-20 Common Stock 22500 22500 D Stock Options (to buy) 39.01 2009-10-03 2018-10-03 Common Stock 22500 22500 D Stock Options (to buy) 44.78 2009-02-20 2018-02-20 Common Stock 45000 45000 D Stock Options (to buy) 35.35 2008-10-01 2017-10-01 Common Stock 90000 90000 D 10,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment. These shares vest in three equal increments on 10/1/08, 10/1/09 and 10/1/10. These options vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13. These options vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12. These optons vest in three equal increments on 11/20/09, 11/20/10 and 11/20/11. These options vest in three equal increments on 10/3/09, 10/03/10 and 10/3/11. These options vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11. These options vest in three equal increments on 10/1/08, 10/1/09 and10/1/10. Lisa C. Noecker attorney-in-fact for Daniel G. Darazsdi 2010-03-01 -----END PRIVACY-ENHANCED MESSAGE-----